CN115211568A - 一种用于提高免疫力调整胃肠道防癌初乳肽及制备方法 - Google Patents
一种用于提高免疫力调整胃肠道防癌初乳肽及制备方法 Download PDFInfo
- Publication number
- CN115211568A CN115211568A CN202210845528.3A CN202210845528A CN115211568A CN 115211568 A CN115211568 A CN 115211568A CN 202210845528 A CN202210845528 A CN 202210845528A CN 115211568 A CN115211568 A CN 115211568A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- colostrum
- peptide
- old
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 42
- 210000003022 colostrum Anatomy 0.000 title claims abstract description 39
- 235000021277 colostrum Nutrition 0.000 title claims abstract description 39
- 230000036039 immunity Effects 0.000 title claims abstract description 29
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 title claims abstract description 15
- 230000002265 prevention Effects 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims description 11
- 230000001105 regulatory effect Effects 0.000 title claims description 8
- 239000000843 powder Substances 0.000 claims abstract description 113
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000000463 material Substances 0.000 claims abstract description 22
- 235000020248 camel milk Nutrition 0.000 claims abstract description 17
- 229920001202 Inulin Polymers 0.000 claims abstract description 13
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 13
- 229940029339 inulin Drugs 0.000 claims abstract description 13
- 229960003080 taurine Drugs 0.000 claims abstract description 13
- 241000283690 Bos taurus Species 0.000 claims abstract description 12
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 12
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 12
- 235000008939 whole milk Nutrition 0.000 claims abstract description 12
- 239000006041 probiotic Substances 0.000 claims abstract description 10
- 235000018291 probiotics Nutrition 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims description 23
- 241001608472 Bifidobacterium longum Species 0.000 claims description 11
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 11
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 10
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 10
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 10
- 241000194035 Lactococcus lactis Species 0.000 claims description 8
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 8
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 108010002212 colostrinine Proteins 0.000 claims description 2
- 235000008476 powdered milk Nutrition 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 20
- 210000004369 blood Anatomy 0.000 abstract description 20
- 210000000936 intestine Anatomy 0.000 abstract description 15
- 210000002784 stomach Anatomy 0.000 abstract description 15
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 12
- 230000001093 anti-cancer Effects 0.000 abstract description 8
- 235000016709 nutrition Nutrition 0.000 abstract description 8
- 238000000338 in vitro Methods 0.000 abstract description 7
- 238000001727 in vivo Methods 0.000 abstract description 7
- 230000032683 aging Effects 0.000 abstract description 6
- 230000035764 nutrition Effects 0.000 abstract description 6
- 229920001184 polypeptide Polymers 0.000 abstract description 6
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 6
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 abstract description 5
- 235000012000 cholesterol Nutrition 0.000 abstract description 5
- 235000018102 proteins Nutrition 0.000 abstract description 5
- 102000004169 proteins and genes Human genes 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 abstract description 5
- 208000001132 Osteoporosis Diseases 0.000 abstract description 4
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 abstract description 4
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 abstract description 4
- 239000013589 supplement Substances 0.000 abstract description 4
- 229930003231 vitamin Natural products 0.000 abstract description 4
- 239000011782 vitamin Substances 0.000 abstract description 4
- 235000013343 vitamin Nutrition 0.000 abstract description 4
- 229940088594 vitamin Drugs 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 9
- 230000002708 enhancing effect Effects 0.000 description 7
- 235000013336 milk Nutrition 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 235000013350 formula milk Nutrition 0.000 description 4
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- 239000005862 Whey Substances 0.000 description 3
- 102000007544 Whey Proteins Human genes 0.000 description 3
- 108010046377 Whey Proteins Proteins 0.000 description 3
- 235000021049 nutrient content Nutrition 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000282836 Camelus dromedarius Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种用于提高免疫力调整胃肠道防癌初乳肽,按重量份数计,包括主料成分和辅料成分,主料成分与辅料成分的比例为1:1;所述主料成分包括大豆蛋白粉20~40份、骨胶原蛋白肽10~30份、全脂驼乳粉10‑30份、全脂乳粉5~15份、牛磺酸0.10~0.14份、菊粉1~10份、牛初乳粉1~10份;所述辅料成分包括益生菌0.1~0.4份。本发明提供的初乳肽粉不仅富含蛋白质、维生素与微量物质,能够有效地为老年人补充营养、调理老年人的血糖和肠胃、提高免疫力和预防骨质疏松,而且含有多肽及醋酸生育酚的保健成分,可以降血糖、降血脂、降低胆固醇、调理肠胃的功能,实现调理老人的血糖和肠胃,提高老年人的免疫力、延缓衰老、保护智力和增强体内、体外的抗癌作用。
Description
技术领域
本发明属于奶粉技术领域,具体涉及一种用于提高免疫力调整胃肠道防癌初乳肽及制备方法。
背景技术
初乳来源的富含脯氨酸多肽的研究开始渐热,但其领域主要针对脯氨酸多肽(PRP)糜蛋白酶水解物某些片段的生物活性功能,尤其是在抗氧化、抗衰老、抗癌、抗神经退行性病变的功效。其中,骆驼初乳是富脯氨酸多肽的重要来源之一,骆驼奶已被视为一种不可替代的营养品,骆驼奶除了富含维生素C以外,还含有大量人体所需的不饱和脂肪酸、铁和维生素B和含有较多的类胰岛素因子可以辅助治疗糖尿病。最为特别的是,骆驼奶富含牛奶中所缺少的乳铁传递蛋白和溶解酵素,可强化人体的免疫系统。因此,说骆驼乳对人体具有很好的营养与保健功效。
随着年龄的增长,老年人的基础代谢能力、消化系统、心脑血管系统以及智力等指标日益下降,骆驼奶粉能有效合理地满足老年人摄人营养的需要;并且,除了满足营养需求外,还需要使用合理的、成分全面的、有针对性的配方奶粉来调理老人的血糖和肠胃,提高老年人的免疫力、延缓衰老、保护智力和增强体内和体外的抗癌作用。
综上所述,提供一种用于提高免疫力调整胃肠道防癌初乳肽的初乳肽具有重要意义。
发明内容
本发明的目的在于提供一种用于提高免疫力调整胃肠道防癌初乳肽及制备方法及其制备方法,以解决现有老年人奶粉缺少提高免疫力和调理血糖、肠胃功效和增强体内、体外的抗癌功效的问题,实现针对性的配方奶粉来调理老人的血糖和肠胃,提高老年人的免疫力、延缓衰老、保护智力和增强体内和体外的抗癌作用。
为解决上述技术问题,本发明采用的技术方案是:一种用于提高免疫力调整胃肠道防癌初乳肽,按重量份数计,包括主料成分和辅料成分,其中,主料成分与辅料成分的此例为1∶1;所述主料成分包括大豆蛋白粉20~40份、骨胶原蛋白肽10~30份、全脂驼乳粉10-30份、全脂乳粉5~15份、牛磺酸0.10~0.14份、菊粉1~10份、牛初乳粉1~10份;所述辅料成分包括益生菌0.1~0.4份。
所述益生菌包括植物乳杆菌0.1~0.2份,长双岐杆菌0.1~0.2份,乳酸乳球菌0.1~0.2份。
一种用于提高免疫力调整胃肠道防癌初乳肽及制备方法具体步骤为:
(1)准备原料:取牛磺酸和牛初乳粉、菊粉混匀得粉状A,取植物乳杆菌、长双岐杆菌、乳酸乳球菌混匀得粉状B,取大豆蛋白粉、骨胶原蛋白肽、全脂驼乳粉、全脂乳粉混匀得粉状C,将所得粉状A、粉状B、粉状C混合均匀;
(2)均质:将步骤(1)混合均匀后的粉状倒入均质机中混合均质;
(3)封装:将步骤(2)中均质的粉末分袋包装后,送至仓库储存。
所述所得粉状A、粉状B、粉状C混合均匀时间为30分钟。
本发明的有益效果在于:
本发明提供的初乳肽粉中的生驼粉可以协助糖尿病患减少对胰岛素的需求,对新生儿有益,它不含过敏原对消化性溃疡病患有益、对高血压也有帮助;脱盐乳清粉是非常优质的乳清产品,按照等级不同可以分为D40、D50、D70、D90,婴幼儿奶粉中脱盐乳清粉通常使用D90,脱盐程度较高,调整蛋白质比例;低聚异麦芽糖具有维持肠道有益菌群平衡、抑制病原菌和腐败菌生长、防止便秘、抗肿瘤活性、降低胆固醇、增强人体免疫能力;菊粉具有清热解毒,养肝护肝的功效,调解肠道内菌群的平衡,有效的降低血清总胆固醇和低密度脂蛋白胆固醇,改善血脂状况,能促进微量元素钙,镁的吸收和提高人体的免疫力的功效;醋酸生育酚具有保持各个器官旺盛的机能,发挥延缓衰老,益寿延年作用;亚硒酸钠具有减少癌症或者冠心病的发病率,增强视力或者刺激免疫球蛋白,对治疗高血压引起的心肌炎症能够起到一定的缓解作用。根据上述成分的功效和表1数据可得,本发明提供的初乳肽粉不仅富含蛋白质、维生素与微量物质,能够有效地为老年人补充营养,调理老年人的血糖和肠胃,提高免疫力,预防骨质疏松,而且含有多肽、醋酸生育酚这样的保健成分,可以降血糖、降血脂、降低胆固醇,调理肠胃使得老年人身体更加健康,实现调理老人的血糖和肠胃,提高老年人的免疫力、延缓衰老、保护智力和增强体内、体外的抗癌作用。
具体实施方式
为了本技术领域的人员更好的理解本发明,下面结合以下实施例对本发明作进一步详细描述。以下对本发明的实施例的详细描述并非旨在限制要求保护的本发明的范围,而是仅仅表示本发明的选定实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
一种用于提高免疫力调整胃肠道防癌初乳肽,按重量份数计,包括主料成分和辅料成分,其中,主料成分与辅料成分的此例为1∶1;所述主料成分包括大豆蛋白粉20~40份、骨胶原蛋白肽10~30份、全脂驼乳粉10-30份、全脂乳粉5~15份、牛磺酸0.10~0.14份、菊粉1~10份、牛初乳粉1~10份;所述辅料成分包括益生菌0.1~0.4份,益生菌包括植物乳杆菌0.1~0.2份,长双岐杆菌0.1~0.2份,乳酸乳球菌0.1~0.2份。该配方加工后制成的初乳肽粉不仅富含蛋白质、维生素与微量物质,食用后能够有效地为老年人补充营养,调理老年人的血糖和肠胃,提高免疫力,预防骨质疏松,而且含有醋酸生育酚保健成分可以降血糖、降血脂、降低胆固醇,调理肠胃使得老年人身体更加健康,实现调理老人的血糖和肠胃,提高老年人的免疫力、延缓衰老、保护智力和增强体内、体外的抗癌作用。
实施例1
一种用于提高免疫力调整胃肠道防癌初乳肽,其配方为,包括大豆蛋白粉20~40份、骨胶原蛋白肽10~30份、全脂驼乳粉10-30份、全脂乳粉5~15份、牛磺酸0.10~0.14份、菊粉1~10份、牛初乳粉1~10份,益生菌包括植物乳杆菌0.1~0.2份,长双岐杆菌0.1~0.2份。
其具体制备步骤如下:
1)准备原料:精确称量,取牛磺酸0.10份和牛初乳粉1份、菊粉1份混匀得粉状A,取植物乳杆菌0.1份、长双岐杆菌0.1份、乳酸乳球菌0.1份混匀得粉状B,取大豆蛋白粉20份、骨胶原蛋白肽10份、全脂驼乳粉10份、全脂乳粉5份混匀得粉状C,将所得粉状A、粉状B、粉状C混合均匀;
2)均质:将步骤(1)混合均匀后的粉状倒入均质机中混合均质;
3)封装:将步骤(2)中均质的粉末分袋包装后,送至仓库储存。
4)食用方法,冲调,1杯中倒入约50度左右温开水;2取适量初乳肽粉加入杯中(粉水比例1:7平匀约5克);3搅拌均匀后即可使用。
实施例二
一种用于提高免疫力调整胃肠道防癌初乳肽,其配方为,包括大豆蛋白粉20~40份、骨胶原蛋白肽10~30份、全脂驼乳粉10-30份、全脂乳粉5~15份、牛磺酸0.10~0.14份、菊粉1~10份、牛初乳粉1~10份,益生菌包括植物乳杆菌0.1~0.2份,长双岐杆菌0.1~0.2份。
其具体制备步骤如下:
1)准备原料:精确称量,取牛磺酸0.12份和牛初乳粉5份、菊粉5份混匀得粉状A,取植物乳杆菌0.15份、长双岐杆菌0.15份、乳酸乳球菌0.15份混匀得粉状B,取大豆蛋白粉30份、骨胶原蛋白肽20份、全脂驼乳粉20份、全脂乳粉10份混匀得粉状C,将所得粉状A、粉状B、粉状C混合均匀;
其余步骤按实施例1所述步骤进行。
实施例三
一种用于提高免疫力调整胃肠道防癌初乳肽,其配方为,包括大豆蛋白粉20~40份、骨胶原蛋白肽10~30份、全脂驼乳粉10-30份、全脂乳粉5~15份、牛磺酸0.10~0.14份、菊粉1~10份、牛初乳粉1~10份,益生菌包括植物乳杆菌0.1~0.2份,长双岐杆菌0.1~0.2份。
其具体制备步骤如下:
1)准备原料:精确称量,取牛磺酸0.14份和牛初乳粉10份、菊粉10份混匀得粉状A,取植物乳杆菌0.2份、长双岐杆菌0.2份、乳酸乳球菌0.2份混匀得粉状B,取大豆蛋白粉40份、骨胶原蛋白肽30份、全脂驼乳粉30份、全脂乳粉15份混匀得粉状C,将所得粉状A、粉状B、粉状C混合均匀;
其余步骤按实施例1所述步骤进行。
取实施例1所制得的初乳肽粉测得营养成分表表1。
表一 营养成分表
现有初乳肽奶粉测得营养成分表表2。
表2营养成分表
根据表1和表2中奶粉测得营养成分数据对比可得;
本发明初乳粉测得营养成分含量达到高于现有奶粉的营养成分;因此,本发明的奶粉富含蛋白质、维生素(维生素A、维生素D、维生素E、维生素B、维生素B6和维生素C)以及微量元素(钙、铁、锌、硒、牛磺酸),有效地为老年人补充营养,调理老年人的血糖和肠胃,提高免疫力,预防骨质疏松,而且含有多肽、醋酸生育酚这样的保健成分,可以降血糖、降血脂、降低胆固醇,调理肠胃使得老年人身体更加健康,实现调理老人的血糖和肠胃,提高老年人的免疫力、延缓衰老、保护智力和增强体内、体外的抗癌作用。
以上所述,仅是本发明的较佳实施例,并非对本发明作任何限制,凡是根据本发明技术实质对以上实施例所作的任何简单修改、变更以及,均仍属于本发明技术方案的保护范围内。
Claims (4)
1.一种用于提高免疫力调整胃肠道防癌初乳肽,其特征在于:按重量份数计,包括主料成分和辅料成分,其中,主料成分与辅料成分的比例为1:1;主料成分包括大豆蛋白粉20~40份、骨胶原蛋白肽10~30份、全脂驼乳粉10-30份、全脂乳粉5~15份、牛磺酸0.10~0.14份、菊粉1~10份、牛初乳粉1~10份,辅料成分包括益生菌0.1~0.4份。
2.根据权利要求1所述的一种用于提高免疫力调整胃肠道防癌初乳肽,其特征在于:所述益生菌包括植物乳杆菌0.1~0.2份,长双岐杆菌0.1~0.2份,乳酸乳球菌0.1~0.2份。
3.根据权利要求1或2所述的一种用于提高免疫力调整胃肠道防癌初乳肽及制备方法,其特征在于:具体步骤为:
(1)准备原料:取牛磺酸和牛初乳粉、菊粉混匀得粉状A,取植物乳杆菌、长双岐杆菌、乳酸乳球菌混匀得粉状B,取大豆蛋白粉、骨胶原蛋白肽、全脂驼乳粉、全脂乳粉混匀得粉状C,将所得粉状A、粉状B、粉状C混合均匀;
(2)均质:将步骤(1)混合均匀后的粉状倒入均质机中混合均质;
(3)封装:将步骤(2)中均质的粉末分袋包装后,送至仓库储存。
4.根据权利要求3所述的一种用于提高免疫力调整胃肠道防癌初乳肽及制备方法,其特征在于:所述所得粉状A、粉状B、粉状C混合均匀时间为30分钟。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210845528.3A CN115211568A (zh) | 2022-07-18 | 2022-07-18 | 一种用于提高免疫力调整胃肠道防癌初乳肽及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210845528.3A CN115211568A (zh) | 2022-07-18 | 2022-07-18 | 一种用于提高免疫力调整胃肠道防癌初乳肽及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115211568A true CN115211568A (zh) | 2022-10-21 |
Family
ID=83612596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210845528.3A Pending CN115211568A (zh) | 2022-07-18 | 2022-07-18 | 一种用于提高免疫力调整胃肠道防癌初乳肽及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115211568A (zh) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107280014A (zh) * | 2017-08-02 | 2017-10-24 | 安徽金源药业有限公司 | 一种能促进肠道动力的复合益生菌蛋白质粉 |
CN107319528A (zh) * | 2017-07-11 | 2017-11-07 | 安徽全康药业有限公司 | 一种益智补脑婴幼儿营养包制剂 |
CN110959679A (zh) * | 2019-12-03 | 2020-04-07 | 伊犁那拉乳业集团有限公司 | 一种可预防和降低血脂的高钙配方驼乳粉制备方法及组成 |
CN111165801A (zh) * | 2020-01-16 | 2020-05-19 | 山东特康药业有限公司 | 一种用于骨病康复患者的医用营养粉及制备方法 |
CN111671079A (zh) * | 2020-05-13 | 2020-09-18 | 优益生活(北京)健康科技有限公司 | 一种复合益生菌粉组合物及其制备方法 |
CN112535213A (zh) * | 2020-11-17 | 2021-03-23 | 北京海杰鉝铔健康管理有限公司 | 一种骆驼奶蛋白粉配方及其制备工艺 |
CN113647469A (zh) * | 2021-08-16 | 2021-11-16 | 广州慧营智能科技有限公司 | 一种促进骨骼生长的儿童配方奶粉及其制备方法 |
CN113841739A (zh) * | 2021-09-29 | 2021-12-28 | 陕西金雪莲丝路乳业集团有限公司 | 一种调理血糖、肠胃、三高人群的奶粉配方及其制备方法 |
-
2022
- 2022-07-18 CN CN202210845528.3A patent/CN115211568A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107319528A (zh) * | 2017-07-11 | 2017-11-07 | 安徽全康药业有限公司 | 一种益智补脑婴幼儿营养包制剂 |
CN107280014A (zh) * | 2017-08-02 | 2017-10-24 | 安徽金源药业有限公司 | 一种能促进肠道动力的复合益生菌蛋白质粉 |
CN110959679A (zh) * | 2019-12-03 | 2020-04-07 | 伊犁那拉乳业集团有限公司 | 一种可预防和降低血脂的高钙配方驼乳粉制备方法及组成 |
CN111165801A (zh) * | 2020-01-16 | 2020-05-19 | 山东特康药业有限公司 | 一种用于骨病康复患者的医用营养粉及制备方法 |
CN111671079A (zh) * | 2020-05-13 | 2020-09-18 | 优益生活(北京)健康科技有限公司 | 一种复合益生菌粉组合物及其制备方法 |
CN112535213A (zh) * | 2020-11-17 | 2021-03-23 | 北京海杰鉝铔健康管理有限公司 | 一种骆驼奶蛋白粉配方及其制备工艺 |
CN113647469A (zh) * | 2021-08-16 | 2021-11-16 | 广州慧营智能科技有限公司 | 一种促进骨骼生长的儿童配方奶粉及其制备方法 |
CN113841739A (zh) * | 2021-09-29 | 2021-12-28 | 陕西金雪莲丝路乳业集团有限公司 | 一种调理血糖、肠胃、三高人群的奶粉配方及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101278736B (zh) | 一种适合亚洲人群营养支持的均衡肠内全营养制剂 | |
US9943097B2 (en) | Nutritional composition | |
EP1841330B1 (en) | Use of infant formula with reduced protein content | |
US20120052132A1 (en) | Compositions and methods for treatment of body weight conditions | |
CN112535283A (zh) | 一种全营养配方粉 | |
WO2019104390A1 (en) | Milk substitute compositions | |
AU2005332128B2 (en) | Food composition for stimulating growth comprising fraction isolated from mammalian colostrum or milk whey | |
JP6325666B2 (ja) | ラクトフェリン−オステオポンチン−鉄複合体 | |
CN113841739A (zh) | 一种调理血糖、肠胃、三高人群的奶粉配方及其制备方法 | |
CN102458135A (zh) | 引发饱食感的奶制品 | |
CN112868803A (zh) | 一种提高母乳营养的配方奶粉及其制备方法 | |
CN111642566A (zh) | 一种有利于儿童身高和智力发育的羊奶粉 | |
JP6037595B2 (ja) | 満腹感誘導組成物及びその製造方法 | |
CN115211568A (zh) | 一种用于提高免疫力调整胃肠道防癌初乳肽及制备方法 | |
CN109892495A (zh) | 一种富硒、锌和铁鸡饲料及富硒、锌和铁鸡蛋的生产方法 | |
CN113678897A (zh) | 一种促进孕产妇营养吸收的配方奶粉及其制备方法 | |
JP2004115509A (ja) | 破骨細胞分化抑制因子産生促進剤 | |
Tiwari et al. | Nutritional Values and Therapeutic Uses of Capra hircus Milk. | |
CN106721346A (zh) | 犬猫高吸收蛋白复合物及其制作方法 | |
Shaikh et al. | Chemistry, nutritional properties and application of Mare's milk: A review | |
Saidalikutty et al. | Exclusive cow’s milk intake and asymptomatic anaemia | |
Thesiya et al. | Colostrum as a Source of Nutraceuticals | |
KR930008102B1 (ko) | 알콕시글리세롤을 첨가한 유아식 | |
EP4241580A2 (en) | Protein compositions with high isoelectric proteins | |
CN113575687A (zh) | 一种促进儿童成长的配方奶粉及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |